Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients with Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma after Early Failure of FOLFIRINOX

Timothy J. Vreeland, Florencia McAllister, Sanaz Javadi, Laura R. Prakash, David R. Fogelman, Linus Ho, Gauri Varadhachary, Thomas A. Aloia, Jean Nicolas Vauthey, Jeffrey E. Lee, Michael P. Kim, Matthew H.G. Katz, Ching Wei D. Tzeng

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients with Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma after Early Failure of FOLFIRINOX'. Together they form a unique fingerprint.

Medicine & Life Sciences